Skip to main content

$0.018 -0.001 (-5.26%)

High

$0.02

Low

$0.02

Trades

52

Turnover

$20,686

Volume

1,123,417
30 June 2023 at 4:10pm
Register to track BNO and receive email alerts.
Subject
BNO Ann: Proposed issue of securities - BNO

BNO Ann: BNO files Form 20-F with the SEC

BNO Ann: 2022 Notice of AGM/Proxy Form

BNO Ann: 2022 Corporate Governance Statement and Appendix 4G

BNO Ann: 2022 Annual Report

BNO Ann: Participation in Cantor Neurology & Psychiatry Conference

BNO Ann: Corporate Presentation September 2022

BNO Ann: Bionomics to Host KOL Webinar on BNC210 and SAD

BNO Ann: Notification of cessation of securities - BNO

BNO Ann: Bionomics reports Full Year Financial Results 30 June 2022

BNO Ann: Appendix 4E and Full Year Financial Statements 30 June 2022

BNO Ann: R&D tax incentive refund for FY2021 received

BNO Ann: Quarterly Activities/Appendix 4C Cash Flow Report

BNO Ann: Notification regarding unquoted securities - BNO

BNO Ann: Notification of cessation of securities - BNO

BNO Ann: Ceasing to be a substantial holder

BNO Ann: Ceasing to be a substantial holder

BNO Ann: Bionomics Investor Webinar

BNO Ann: Change of Directors Interest Notice MD

BNO Ann: BNO to Participate in Upcoming Investor Conferences

BNO Ann: Quarterly Activities/Appendix 4C Cash Flow Report

BNO Ann: Notification of cessation of securities - BNO

BNO Ann: Bionomics Receives $264k Licensing Revenue from CTx

BNO Ann: Half Yearly Report and Accounts

BNO Ann: Quarterly Activities/Appendix 4C Cash Flow Report Dec 2021

BNO Ann: Change in substantial holding

BNO Ann: Becoming a substantial holder

BNO Ann: Change in substantial holding

BNO Ann: Becoming a substantial holder

BNO Ann: Notification of cessation of securities - BNO

BNO Ann: Bionomics Presentation for H.C. Wainwright BioConnect 2022

BNO Ann: Change in substantial holding

BNO Ann: BNO to Present at H.C.Wainwright BioConnect Conference

BNO Ann: Full Exercise of Underwriter's Option to Purchase ADSs in US

BNO Ann: Application for quotation of securities - BNO

BNO Ann: Cleansing Notice

BNO Ann: Proposed issue of securities - BNO

BNO Ann: Becoming a substantial holder

BNO Ann: Change in substantial holding

BNO Ann: Phase 2 PREVAIL Study of BNC210 for SAD Treatment Initiated

BNO Ann: Final Director's Interest Notice - M Kaye

BNO Ann: Resignation of Director - M Kaye

BNO Ann: Becoming a substantial holder

BNO Ann: Change of Director's Interest Notice AF

BNO Ann: Change of Director's Interest Notice EDS

BNO Ann: Notification regarding unquoted securities - BNO

BNO Ann: Change in substantial holding

BNO Ann: Bionomics Announces Closing of IPO in the US

BNO Ann: Cleansing Notice

BNO Ann: Application for quotation of securities - BNO

Register to track BNO and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX